Medicated brain stent for clogged arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new type of stent coated with a medicine to treat narrowed brain arteries. It may help reduce the risk of future strokes compared to standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had a stroke or TIA in the past 6 months caused by a narrowed brain artery.
- The narrowing must be serious (70–99% blocked) and you must have tried blood thinners without enough relief, or have other issues like poor blood flow.
- You cannot have had a stroke within the last 2 weeks.
- You cannot have another severe narrowing in a brain artery that needs treatment, or a major disability (like needing help to walk).
- Candidates should generally be in good health, without recent heart attacks, allergies to stent materials, or pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
This study tests a special stent that slowly releases a drug (rapamycin) to keep a narrowed brain artery open. It is for patients who have had strokes despite medical treatment.
This study tests a new type of expandable stent for people with narrowed arteries in the brain that keep causing strokes or mini-strokes despite medications. The goal is to see if the stent is safe and effective in preventing further events.
This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
This trial compares two treatments for people with a severely narrowed artery inside the brain that has recently caused a mini-stroke or stroke. One treatment uses a tiny mesh tube (stent) to open the artery; the other is medication alone. The goal is to see which approach better helps prevent future strokes.
Hear when a new Intracranial Arteriosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.